Vergent Bioscience, Inc.
Amendment
CIK: 0001741495·Biotechnology·DELAWARE·Filed: Feb 18, 2025
Total Offering
$5,000,000
Amount Sold
$3,750,000
Investors
5
First Sale
Feb 3, 2025
Offering Details
- Type
- Debt, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| John Santini | Related Person |
| Ryan Egeland | Related Person |
| Jeff Julkowski | Related Person |
| Samuel Dean Banks | Related Person |
| Douglas Kohrs | Related Person |
| Raymond Wong | Related Person |
| Bobby Helmedag | Related Person |
| Anita Watkins | Related Person |
| Jeffrey Yurecko | Related Person |
Company
SEC Filing
0001741495-25-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free